Cargando…

Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis

Heparin‐induced thrombocytopenia (HIT) is a prothrombotic state that can affect patients with chronic kidney disease (CKD) on hemodialysis (HD). This case highlights the potential usefulness of apixaban therapy for patients with HIT and CKD on HD.

Detalles Bibliográficos
Autores principales: Trujillo Agudelo, Daniela, Ramirez Quintero, Juan D., Arango Barrientos, Marcos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230604/
https://www.ncbi.nlm.nih.gov/pubmed/30455909
http://dx.doi.org/10.1002/ccr3.1817
_version_ 1783370108624699392
author Trujillo Agudelo, Daniela
Ramirez Quintero, Juan D.
Arango Barrientos, Marcos
author_facet Trujillo Agudelo, Daniela
Ramirez Quintero, Juan D.
Arango Barrientos, Marcos
author_sort Trujillo Agudelo, Daniela
collection PubMed
description Heparin‐induced thrombocytopenia (HIT) is a prothrombotic state that can affect patients with chronic kidney disease (CKD) on hemodialysis (HD). This case highlights the potential usefulness of apixaban therapy for patients with HIT and CKD on HD.
format Online
Article
Text
id pubmed-6230604
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62306042018-11-19 Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis Trujillo Agudelo, Daniela Ramirez Quintero, Juan D. Arango Barrientos, Marcos Clin Case Rep Case Reports Heparin‐induced thrombocytopenia (HIT) is a prothrombotic state that can affect patients with chronic kidney disease (CKD) on hemodialysis (HD). This case highlights the potential usefulness of apixaban therapy for patients with HIT and CKD on HD. John Wiley and Sons Inc. 2018-09-25 /pmc/articles/PMC6230604/ /pubmed/30455909 http://dx.doi.org/10.1002/ccr3.1817 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Trujillo Agudelo, Daniela
Ramirez Quintero, Juan D.
Arango Barrientos, Marcos
Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis
title Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis
title_full Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis
title_fullStr Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis
title_full_unstemmed Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis
title_short Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis
title_sort successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230604/
https://www.ncbi.nlm.nih.gov/pubmed/30455909
http://dx.doi.org/10.1002/ccr3.1817
work_keys_str_mv AT trujilloagudelodaniela successfultreatmentofheparininducedthrombocytopeniawithapixabaninapatientwithchronickidneydiseaserequiringhemodialysis
AT ramirezquinterojuand successfultreatmentofheparininducedthrombocytopeniawithapixabaninapatientwithchronickidneydiseaserequiringhemodialysis
AT arangobarrientosmarcos successfultreatmentofheparininducedthrombocytopeniawithapixabaninapatientwithchronickidneydiseaserequiringhemodialysis